The Development of PARP Inhibitors in Ovarian Cancer: From Bench to Bedside

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2015.394
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

PARP Inhibitors in Ovarian Cancer

2013English

Extending the Scope of PARP Inhibitors in Ovarian Cancer

The Lancet Oncology
Oncology
2019English

Mitochondrial DNA Mutations in Cancer - From Bench to Bedside

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2010English

Targeting the IDO1 Pathway in Cancer: From Bench to Bedside

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2018English

From Bench to Bedside

Circulation Journal
MedicineCardiovascular MedicineCardiology
2008English

Development of Targeted Alpha Therapy From Bench to Bedside

Journal of Medical Imaging and Radiation Sciences
RadiologicalRadiologyNuclear MedicineUltrasound TechnologyImaging
2019English

Ebola From Bedside to Bench

Cell
BiochemistryGeneticsMolecular Biology
2019English

CXCR2: From Bench to Bedside

Frontiers in Immunology
AllergyImmunology
2012English

Sepsis: From Bench to Bedside

Clinics
Medicine
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy